During the last session, Immunic Inc (NASDAQ:IMUX)’s traded shares were 0.36 million, with the beta value of the company hitting 1.92. The 52-week high for the IMUX share is $2.11, that puts it down -83.48 from that peak though still a striking 20.0% gain since the share price plummeted to a 52-week low of $0.92. The company’s market capitalization is $103.59M, and the average trade volume was 935.76K shares over the past three months.
Immunic Inc (IMUX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IMUX has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.24.
Immunic Inc (NASDAQ:IMUX) trade information
The stock’s 5-day price performance is -3.36%, and it has moved by 16.76% in 30 days. Based on these gigs, the overall price performance for the year is -23.33%.
The consensus price target of analysts on Wall Street is $5, which implies an increase of 77.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, IMUX is trading at a discount of -334.78% off the target high and -334.78% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 31.12%. While earnings are projected to return 54.58% in 2025, the next five years will return 32.90% per annum.
IMUX Dividends
Immunic Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 8.9 million shares, is of AVIDITY PARTNERS MANAGEMENT LP’s that is approximately 9.15% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.88 million.
Also, the Mutual Funds coming in first place with the largest holdings of Immunic Inc (IMUX) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 2.63 shares. This amounts to just over 2.92 percent of the company’s overall shares, with a $3.02 million market value. The same data shows that the other fund manager holds slightly less at 1.87, or about 2.08% of the stock, which is worth about $2.15 million.
